HFIT Versus TENS Study for Chronic Low Back and Knee Pain
A Randomized Controlled Clinical Trial Evaluating the Effectiveness of High-frequency Impulse Therapy (HFIT) Versus Transcutaneous Electronic Nerve Stimulator (TENS) for Treatment of Chronic Low Back and Knee Pain
1 other identifier
interventional
325
1 country
1
Brief Summary
A high-frequency impulse therapy (HFIT) device (Enso, San Francisco, CA) is a portable device for the treatment of musculoskeletal pain. This three-arm randomized controlled trial study compares a HFIT group to a standard transcutaneous electrical nerve stimulator (TENS) group and a control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-pain
Started Apr 2023
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2023
CompletedFirst Posted
Study publicly available on registry
April 20, 2023
CompletedStudy Start
First participant enrolled
April 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedJune 8, 2023
June 1, 2023
2 months
April 6, 2023
June 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain MCID
Pain will be measured by the Numeric Pain Rating Scale, ranging from 0 (no pain) to 100 (worst possible pain). The minimal clinically important difference (MCID) of pain will be achieved (0/1) if there is at least a 34% or 23 point improvement, as based on literature.
Baseline and Week 4
Secondary Outcomes (5)
Function MCID (Back)
Baseline and Week 4
Function MCID (Knee)
Baseline and Week 4
Anxiety
Baseline and Week 4
Depression
Baseline and Week 4
Opioid use
Baseline and Week 4
Study Arms (3)
HFIT
EXPERIMENTALParticipants received a HFIT device to treat their chronic pain and took part in a digital MSK program, which provided customized exercise therapy sessions, educational articles, and access to coaches and physical therapists. Participants were encouraged to use the HFIT device for at least 1 hour daily for 4 weeks.
TENS
EXPERIMENTALParticipants received a TENS device to treat their chronic pain and took part in a digital MSK program, which provided customized exercise therapy sessions, educational articles, and access to coaches and physical therapists. Participants were encouraged to use the TENS device for at least 1 hour daily for 4 weeks.
Control
ACTIVE COMPARATORParticipants took part in a digital MSK program, which provided customized exercise therapy sessions, educational articles, and access to coaches and physical therapists.
Interventions
Eligibility Criteria
You may qualify if:
- Age 18 or over and under age 65
- Baseline pain is 40 or more out of 100 on a NPRS
- Member of digital MSK program's chronic back or knee pain program, after January 1, 2023
- Member engaged in the most recent 3 weeks
- Experiencing chronic pain for at least 3 months
- Subject able to understand and provide informed consent
- Has an email account
You may not qualify if:
- Diagnosis of cancer/malignant tumors in the last 5 years
- Back or knee surgery in the last 6 months
- Has a cardiac pacemaker, implanted defibrillator, spinal cord stimulator, pain pump, insulin pump, or any other implanted electronic device
- Patients with history of opioid, alcohol, or drug abuse in the last 1 year
- Cognitive, behavioral, neurologic, or psychiatric disorder (e.g., dementia, Parkinson's, schizophrenia, stroke) that may interfere with the study or prevent the subject from complying with the requirements of the protocol
- Pregnant or plan on becoming pregnant in the next year
- Have epilepsy
- Have cardiovascular disease
- Current pain (in the past 24 hours) is less than 40 out of 100 on a NPRS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hinge Health, Inc
San Francisco, California, 94105, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2023
First Posted
April 20, 2023
Study Start
April 24, 2023
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
June 8, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share